Shih JY - Search Results

1

Neoadjuvant chemotherapy with docetaxel-cisplatin in patients with stage III N2 non-small-cell lung cancer.

Liao WY, Chen JH, Wu M, Shih JY, Chen KY, Ho CC, Yang JC, Yu CJ. Liao WY, et al. Among authors: shih jy. Clin Lung Cancer. 2013 Jul;14(4):418-24. doi: 10.1016/j.cllc.2012.10.003. Epub 2013 Jan 4. Clin Lung Cancer. 2013. PMID: 23291258

2

Small-cell lung cancer presenting with Lambert-Eaton myasthenic syndrome and respiratory failure.

Jiang JR, Shih JY, Wang HC, Wu RM, Yu CJ, Yang PC. Jiang JR, et al. Among authors: shih jy. J Formos Med Assoc. 2002 Dec;101(12):871-4. J Formos Med Assoc. 2002. PMID: 12632823

3

Tumor-associated antigen L6 and the invasion of human lung cancer cells.

Kao YR, Shih JY, Wen WC, Ko YP, Chen BM, Chan YL, Chu YW, Yang PC, Wu CW, Roffler SR. Kao YR, et al. Among authors: shih jy. Clin Cancer Res. 2003 Jul;9(7):2807-16. Clin Cancer Res. 2003. PMID: 12855661

4

Cardiac involvement in malignancies. Case 1. Favorable outcome of a patient with cardiac invasion from non-small-cell lung carcinoma.

Tsai MS, Ko PC, Shih JY, Chang YL, Chen SC, Chiang WC, Chen WJ. Tsai MS, et al. Among authors: shih jy. J Clin Oncol. 2004 Jul 1;22(13):2740-2. doi: 10.1200/JCO.2004.08.104. J Clin Oncol. 2004. PMID: 15226342 No abstract available.

5

Sialyl Lewis antigens: association with MUC5AC protein and correlation with post-operative recurrence of non-small cell lung cancer.

Yu CJ, Shih JY, Lee YC, Shun CT, Yuan A, Yang PC. Yu CJ, et al. Among authors: shih jy. Lung Cancer. 2005 Jan;47(1):59-67. doi: 10.1016/j.lungcan.2004.05.018. Lung Cancer. 2005. PMID: 15603855

6

Prognosis of non-small cell lung cancer patients by detecting circulating cancer cells in the peripheral blood with multiple marker genes.

Sher YP, Shih JY, Yang PC, Roffler SR, Chu YW, Wu CW, Yu CL, Peck K. Sher YP, et al. Among authors: shih jy. Clin Cancer Res. 2005 Jan 1;11(1):173-9. Clin Cancer Res. 2005. PMID: 15671543

7

Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer.

Shih JY, Gow CH, Yu CJ, Yang CH, Chang YL, Tsai MF, Hsu YC, Chen KY, Su WP, Yang PC. Shih JY, et al. Int J Cancer. 2006 Feb 15;118(4):963-9. doi: 10.1002/ijc.21458. Int J Cancer. 2006. PMID: 16152581

8

Acquired gefitinib-resistant mutation of EGFR in a chemonaive lung adenocarcinoma harboring gefitinib-sensitive mutation L858R.

Gow CH, Shih JY, Chang YL, Yu CJ. Gow CH, et al. Among authors: shih jy. PLoS Med. 2005 Sep;2(9):e269. doi: 10.1371/journal.pmed.0020269. Epub 2005 Sep 27. PLoS Med. 2005. PMID: 16173832 Free PMC article. No abstract available.

9

Gefitinib treatment for non-small cell lung cancer -- a study including patients with poor performance status.

Su WP, Yang CH, Yu CJ, Shih JY, Hsu C, Yang PC. Su WP, et al. Among authors: shih jy. J Formos Med Assoc. 2005 Aug;104(8):557-62. J Formos Med Assoc. 2005. PMID: 16193176

10

The significance of estrogen receptor beta in 301 surgically treated non-small cell lung cancers.

Wu CT, Chang YL, Shih JY, Lee YC. Wu CT, et al. Among authors: shih jy. J Thorac Cardiovasc Surg. 2005 Oct;130(4):979-86. doi: 10.1016/j.jtcvs.2005.06.012. J Thorac Cardiovasc Surg. 2005. PMID: 16214508 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

363 results

Search Page

Filters